nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0654	0.108	CbGbCtD
Imiquimod—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0614	0.102	CbGbCtD
Imiquimod—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0614	0.102	CbGbCtD
Imiquimod—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0556	0.092	CbGbCtD
Imiquimod—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0466	0.0771	CbGbCtD
Imiquimod—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0421	0.0697	CbGbCtD
Imiquimod—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0342	0.0567	CbGbCtD
Imiquimod—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0322	0.0533	CbGbCtD
Imiquimod—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0322	0.0533	CbGbCtD
Imiquimod—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0291	0.0482	CbGbCtD
Imiquimod—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0291	0.0482	CbGbCtD
Imiquimod—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0251	0.0416	CbGbCtD
Imiquimod—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0244	0.0404	CbGbCtD
Imiquimod—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0221	0.0365	CbGbCtD
Imiquimod—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0221	0.0365	CbGbCtD
Imiquimod—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0212	0.035	CbGbCtD
Imiquimod—TLR8—lymphoid tissue—acquired immunodeficiency syndrome	0.00751	0.112	CbGeAlD
Imiquimod—TLR8—blood—acquired immunodeficiency syndrome	0.00707	0.105	CbGeAlD
Imiquimod—TLR8—bone marrow—acquired immunodeficiency syndrome	0.00684	0.102	CbGeAlD
Imiquimod—TLR8—lung—acquired immunodeficiency syndrome	0.0062	0.0924	CbGeAlD
Imiquimod—TLR7—lymphoid tissue—acquired immunodeficiency syndrome	0.00474	0.0706	CbGeAlD
Imiquimod—TLR7—blood—acquired immunodeficiency syndrome	0.00446	0.0665	CbGeAlD
Imiquimod—TLR7—spinal cord—acquired immunodeficiency syndrome	0.00429	0.064	CbGeAlD
Imiquimod—TLR8—lymph node—acquired immunodeficiency syndrome	0.00424	0.0632	CbGeAlD
Imiquimod—TLR7—vagina—acquired immunodeficiency syndrome	0.00413	0.0616	CbGeAlD
Imiquimod—TLR7—lung—acquired immunodeficiency syndrome	0.00391	0.0583	CbGeAlD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—CCL4—acquired immunodeficiency syndrome	0.00361	0.0676	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—CCL4—acquired immunodeficiency syndrome	0.00282	0.0528	CbGpPWpGaD
Imiquimod—TLR7—brain—acquired immunodeficiency syndrome	0.00277	0.0412	CbGeAlD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—CCL4—acquired immunodeficiency syndrome	0.00274	0.0512	CbGpPWpGaD
Imiquimod—TLR7—lymph node—acquired immunodeficiency syndrome	0.00267	0.0399	CbGeAlD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—CCL3—acquired immunodeficiency syndrome	0.00247	0.0462	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—MBL2—acquired immunodeficiency syndrome	0.00222	0.0416	CbGpPWpGaD
Imiquimod—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00219	0.0327	CbGeAlD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CCL4—acquired immunodeficiency syndrome	0.00214	0.04	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IFNA1—acquired immunodeficiency syndrome	0.00201	0.0376	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—CCL3—acquired immunodeficiency syndrome	0.00193	0.036	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—CCL3—acquired immunodeficiency syndrome	0.00187	0.035	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—MBL2—acquired immunodeficiency syndrome	0.00168	0.0315	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.0016	0.0299	CbGpPWpGaD
Imiquimod—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00159	0.0237	CbGeAlD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.00157	0.0294	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IFNA1—acquired immunodeficiency syndrome	0.00152	0.0285	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CCL3—acquired immunodeficiency syndrome	0.00146	0.0273	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.00125	0.0233	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.00121	0.0226	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.00119	0.0222	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000944	0.0177	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000865	0.0162	CbGpPWpGaD
Imiquimod—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000843	0.0126	CbGeAlD
Imiquimod—CYP1A2—blood—acquired immunodeficiency syndrome	0.000803	0.012	CbGeAlD
Imiquimod—TLR8—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000711	0.0133	CbGpPWpGaD
Imiquimod—CYP1A2—lung—acquired immunodeficiency syndrome	0.000704	0.0105	CbGeAlD
Imiquimod—TLR7—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000656	0.0123	CbGpPWpGaD
Imiquimod—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.00061	0.0091	CbGeAlD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000605	0.0113	CbGpPWpGaD
Imiquimod—CYP3A4—blood—acquired immunodeficiency syndrome	0.000581	0.00867	CbGeAlD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	0.000559	0.0105	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000558	0.0104	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	0.000549	0.0103	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000539	0.0101	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	0.00053	0.00993	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000504	0.00944	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000502	0.0094	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000488	0.00914	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	0.000472	0.00884	CbGpPWpGaD
Imiquimod—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000472	0.00703	CbGeAlD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000458	0.00858	CbGpPWpGaD
Imiquimod—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000454	0.00677	CbGeAlD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—acquired immunodeficiency syndrome	0.000424	0.00794	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000423	0.00791	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—IL6—acquired immunodeficiency syndrome	0.000416	0.00779	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MBL2—acquired immunodeficiency syndrome	0.000414	0.00775	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—acquired immunodeficiency syndrome	0.000402	0.00752	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000382	0.00715	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	0.000381	0.00713	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.00038	0.00712	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000378	0.00708	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	0.000377	0.00705	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.00037	0.00693	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	0.000358	0.0067	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CCR2—acquired immunodeficiency syndrome	0.000325	0.00608	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MBL2—acquired immunodeficiency syndrome	0.000314	0.00588	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000292	0.00547	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	0.000289	0.00541	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000286	0.00536	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	0.000285	0.00535	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD79A—acquired immunodeficiency syndrome	0.000284	0.00531	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CCR2—acquired immunodeficiency syndrome	0.000246	0.00461	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000231	0.00433	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD8A—acquired immunodeficiency syndrome	0.000229	0.00428	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CSF2—acquired immunodeficiency syndrome	0.000229	0.00428	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000226	0.00422	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000222	0.00415	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HLA-B—acquired immunodeficiency syndrome	0.00022	0.00412	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD79A—acquired immunodeficiency syndrome	0.000215	0.00403	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000175	0.00328	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD8A—acquired immunodeficiency syndrome	0.000173	0.00325	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CSF2—acquired immunodeficiency syndrome	0.000173	0.00325	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000171	0.0032	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000167	0.00312	CbGpPWpGaD
Imiquimod—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000156	0.000565	CcSEcCtD
Imiquimod—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000564	CcSEcCtD
Imiquimod—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000564	CcSEcCtD
Imiquimod—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.000563	CcSEcCtD
Imiquimod—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000155	0.000561	CcSEcCtD
Imiquimod—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000154	0.000561	CcSEcCtD
Imiquimod—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.00056	CcSEcCtD
Imiquimod—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000154	0.00056	CcSEcCtD
Imiquimod—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000154	0.000559	CcSEcCtD
Imiquimod—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000154	0.000558	CcSEcCtD
Imiquimod—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000154	0.000558	CcSEcCtD
Imiquimod—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000557	CcSEcCtD
Imiquimod—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000557	CcSEcCtD
Imiquimod—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000556	CcSEcCtD
Imiquimod—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000556	CcSEcCtD
Imiquimod—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000556	CcSEcCtD
Imiquimod—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000554	CcSEcCtD
Imiquimod—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000554	CcSEcCtD
Imiquimod—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000553	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000552	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000551	CcSEcCtD
Imiquimod—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000151	0.00055	CcSEcCtD
Imiquimod—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000151	0.00055	CcSEcCtD
Imiquimod—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.00055	CcSEcCtD
Imiquimod—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.00055	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.000549	CcSEcCtD
Imiquimod—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000549	CcSEcCtD
Imiquimod—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000548	CcSEcCtD
Imiquimod—Pain—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000545	CcSEcCtD
Imiquimod—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000545	CcSEcCtD
Imiquimod—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00015	0.000545	CcSEcCtD
Imiquimod—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000545	CcSEcCtD
Imiquimod—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000544	CcSEcCtD
Imiquimod—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000543	CcSEcCtD
Imiquimod—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.000542	CcSEcCtD
Imiquimod—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.000542	CcSEcCtD
Imiquimod—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000149	0.000542	CcSEcCtD
Imiquimod—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.000541	CcSEcCtD
Imiquimod—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000541	CcSEcCtD
Imiquimod—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000149	0.00054	CcSEcCtD
Imiquimod—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000149	0.00054	CcSEcCtD
Imiquimod—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000538	CcSEcCtD
Imiquimod—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000537	CcSEcCtD
Imiquimod—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000536	CcSEcCtD
Imiquimod—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000535	CcSEcCtD
Imiquimod—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000535	CcSEcCtD
Imiquimod—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000535	CcSEcCtD
Imiquimod—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000533	CcSEcCtD
Imiquimod—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000533	CcSEcCtD
Imiquimod—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000146	0.000532	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000532	CcSEcCtD
Imiquimod—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.00053	CcSEcCtD
Imiquimod—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000529	CcSEcCtD
Imiquimod—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000527	CcSEcCtD
Imiquimod—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000145	0.000526	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000525	CcSEcCtD
Imiquimod—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000525	CcSEcCtD
Imiquimod—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000524	CcSEcCtD
Imiquimod—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000524	CcSEcCtD
Imiquimod—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000523	CcSEcCtD
Imiquimod—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000144	0.000523	CcSEcCtD
Imiquimod—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000523	CcSEcCtD
Imiquimod—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000144	0.000522	CcSEcCtD
Imiquimod—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000144	0.000522	CcSEcCtD
Imiquimod—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000521	CcSEcCtD
Imiquimod—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.00052	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.00052	CcSEcCtD
Imiquimod—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.00052	CcSEcCtD
Imiquimod—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000143	0.00052	CcSEcCtD
Imiquimod—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.00052	CcSEcCtD
Imiquimod—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000518	CcSEcCtD
Imiquimod—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.000518	CcSEcCtD
Imiquimod—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000515	CcSEcCtD
Imiquimod—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000515	CcSEcCtD
Imiquimod—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.000515	CcSEcCtD
Imiquimod—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.000515	CcSEcCtD
Imiquimod—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000514	CcSEcCtD
Imiquimod—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000142	0.000514	CcSEcCtD
Imiquimod—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000513	CcSEcCtD
Imiquimod—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000513	CcSEcCtD
Imiquimod—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000141	0.000512	CcSEcCtD
Imiquimod—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000511	CcSEcCtD
Imiquimod—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000511	CcSEcCtD
Imiquimod—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000511	CcSEcCtD
Imiquimod—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.00051	CcSEcCtD
Imiquimod—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000509	CcSEcCtD
Imiquimod—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000508	CcSEcCtD
Imiquimod—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000508	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000507	CcSEcCtD
Imiquimod—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000507	CcSEcCtD
Imiquimod—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000505	CcSEcCtD
Imiquimod—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000505	CcSEcCtD
Imiquimod—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000504	CcSEcCtD
Imiquimod—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000504	CcSEcCtD
Imiquimod—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000503	CcSEcCtD
Imiquimod—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000139	0.000503	CcSEcCtD
Imiquimod—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000138	0.000502	CcSEcCtD
Imiquimod—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000501	CcSEcCtD
Imiquimod—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000499	CcSEcCtD
Imiquimod—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.000499	CcSEcCtD
Imiquimod—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.000499	CcSEcCtD
Imiquimod—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000498	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000498	CcSEcCtD
Imiquimod—Rash—Stavudine—acquired immunodeficiency syndrome	0.000137	0.000498	CcSEcCtD
Imiquimod—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000497	CcSEcCtD
Imiquimod—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000137	0.000497	CcSEcCtD
Imiquimod—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.000497	CcSEcCtD
Imiquimod—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000496	CcSEcCtD
Imiquimod—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.000496	CcSEcCtD
Imiquimod—Headache—Stavudine—acquired immunodeficiency syndrome	0.000136	0.000494	CcSEcCtD
Imiquimod—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000136	0.000494	CcSEcCtD
Imiquimod—TLR8—Immune System—IFNG—acquired immunodeficiency syndrome	0.000136	0.00255	CbGpPWpGaD
Imiquimod—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000493	CcSEcCtD
Imiquimod—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000493	CcSEcCtD
Imiquimod—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000136	0.000492	CcSEcCtD
Imiquimod—Rash—Abacavir—acquired immunodeficiency syndrome	0.000135	0.00049	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000135	0.00253	CbGpPWpGaD
Imiquimod—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000135	0.00049	CcSEcCtD
Imiquimod—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.00049	CcSEcCtD
Imiquimod—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000489	CcSEcCtD
Imiquimod—Headache—Abacavir—acquired immunodeficiency syndrome	0.000134	0.000487	CcSEcCtD
Imiquimod—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000486	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000486	CcSEcCtD
Imiquimod—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000134	0.000485	CcSEcCtD
Imiquimod—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000134	0.000485	CcSEcCtD
Imiquimod—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000482	CcSEcCtD
Imiquimod—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000482	CcSEcCtD
Imiquimod—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.00048	CcSEcCtD
Imiquimod—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000479	CcSEcCtD
Imiquimod—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000479	CcSEcCtD
Imiquimod—TLR8—Immune System—CD4—acquired immunodeficiency syndrome	0.000131	0.00246	CbGpPWpGaD
Imiquimod—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000476	CcSEcCtD
Imiquimod—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000476	CcSEcCtD
Imiquimod—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000476	CcSEcCtD
Imiquimod—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000475	CcSEcCtD
Imiquimod—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000475	CcSEcCtD
Imiquimod—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000474	CcSEcCtD
Imiquimod—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000473	CcSEcCtD
Imiquimod—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.000471	CcSEcCtD
Imiquimod—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000129	0.00047	CcSEcCtD
Imiquimod—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000129	0.00047	CcSEcCtD
Imiquimod—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000469	CcSEcCtD
Imiquimod—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000129	0.000469	CcSEcCtD
Imiquimod—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000129	0.000469	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000468	CcSEcCtD
Imiquimod—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000467	CcSEcCtD
Imiquimod—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000464	CcSEcCtD
Imiquimod—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000464	CcSEcCtD
Imiquimod—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000127	0.000462	CcSEcCtD
Imiquimod—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000461	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.00046	CcSEcCtD
Imiquimod—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.00046	CcSEcCtD
Imiquimod—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000458	CcSEcCtD
Imiquimod—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000126	0.000458	CcSEcCtD
Imiquimod—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000458	CcSEcCtD
Imiquimod—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000456	CcSEcCtD
Imiquimod—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000456	CcSEcCtD
Imiquimod—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000456	CcSEcCtD
Imiquimod—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000456	CcSEcCtD
Imiquimod—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000125	0.000454	CcSEcCtD
Imiquimod—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000452	CcSEcCtD
Imiquimod—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000451	CcSEcCtD
Imiquimod—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000446	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000446	CcSEcCtD
Imiquimod—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000444	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000443	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—IL6—acquired immunodeficiency syndrome	0.000122	0.00228	CbGpPWpGaD
Imiquimod—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000443	CcSEcCtD
Imiquimod—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000442	CcSEcCtD
Imiquimod—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.00044	CcSEcCtD
Imiquimod—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000439	CcSEcCtD
Imiquimod—TLR8—Immune System—IL2—acquired immunodeficiency syndrome	0.000121	0.00226	CbGpPWpGaD
Imiquimod—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000439	CcSEcCtD
Imiquimod—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000436	CcSEcCtD
Imiquimod—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000436	CcSEcCtD
Imiquimod—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.000436	CcSEcCtD
Imiquimod—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000436	CcSEcCtD
Imiquimod—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000435	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.00012	0.00224	CbGpPWpGaD
Imiquimod—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000432	CcSEcCtD
Imiquimod—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000432	CcSEcCtD
Imiquimod—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000432	CcSEcCtD
Imiquimod—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000431	CcSEcCtD
Imiquimod—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.00043	CcSEcCtD
Imiquimod—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000426	CcSEcCtD
Imiquimod—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000426	CcSEcCtD
Imiquimod—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000425	CcSEcCtD
Imiquimod—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000424	CcSEcCtD
Imiquimod—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000423	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000423	CcSEcCtD
Imiquimod—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000422	CcSEcCtD
Imiquimod—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000116	0.000422	CcSEcCtD
Imiquimod—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000422	CcSEcCtD
Imiquimod—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000422	CcSEcCtD
Imiquimod—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.00042	CcSEcCtD
Imiquimod—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000419	CcSEcCtD
Imiquimod—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000414	CcSEcCtD
Imiquimod—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000412	CcSEcCtD
Imiquimod—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000408	CcSEcCtD
Imiquimod—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000408	CcSEcCtD
Imiquimod—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.000407	CcSEcCtD
Imiquimod—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000406	CcSEcCtD
Imiquimod—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000406	CcSEcCtD
Imiquimod—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000406	CcSEcCtD
Imiquimod—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000403	CcSEcCtD
Imiquimod—Rash—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000402	CcSEcCtD
Imiquimod—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000402	CcSEcCtD
Imiquimod—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.0004	CcSEcCtD
Imiquimod—Headache—Indinavir—acquired immunodeficiency syndrome	0.00011	0.0004	CcSEcCtD
Imiquimod—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000398	CcSEcCtD
Imiquimod—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000395	CcSEcCtD
Imiquimod—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000393	CcSEcCtD
Imiquimod—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000389	CcSEcCtD
Imiquimod—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000387	CcSEcCtD
Imiquimod—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000387	CcSEcCtD
Imiquimod—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000383	CcSEcCtD
Imiquimod—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000383	CcSEcCtD
Imiquimod—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000381	CcSEcCtD
Imiquimod—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.00038	CcSEcCtD
Imiquimod—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.00038	CcSEcCtD
Imiquimod—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000379	CcSEcCtD
Imiquimod—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000378	CcSEcCtD
Imiquimod—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000378	CcSEcCtD
Imiquimod—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000377	CcSEcCtD
Imiquimod—TLR7—Immune System—IFNG—acquired immunodeficiency syndrome	0.000103	0.00193	CbGpPWpGaD
Imiquimod—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000368	CcSEcCtD
Imiquimod—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000367	CcSEcCtD
Imiquimod—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000365	CcSEcCtD
Imiquimod—Rash—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000364	CcSEcCtD
Imiquimod—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000363	CcSEcCtD
Imiquimod—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000363	CcSEcCtD
Imiquimod—TLR7—Immune System—CD4—acquired immunodeficiency syndrome	9.96e-05	0.00186	CbGpPWpGaD
Imiquimod—Headache—Delavirdine—acquired immunodeficiency syndrome	9.95e-05	0.000361	CcSEcCtD
Imiquimod—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	9.93e-05	0.000361	CcSEcCtD
Imiquimod—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.86e-05	0.000358	CcSEcCtD
Imiquimod—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.71e-05	0.000353	CcSEcCtD
Imiquimod—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.67e-05	0.000351	CcSEcCtD
Imiquimod—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.67e-05	0.000351	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	9.64e-05	0.0018	CbGpPWpGaD
Imiquimod—Pruritus—Lamivudine—acquired immunodeficiency syndrome	9.54e-05	0.000346	CcSEcCtD
Imiquimod—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.43e-05	0.000342	CcSEcCtD
Imiquimod—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.35e-05	0.000339	CcSEcCtD
Imiquimod—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.34e-05	0.000339	CcSEcCtD
Imiquimod—Rash—Ritonavir—acquired immunodeficiency syndrome	9.26e-05	0.000336	CcSEcCtD
Imiquimod—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.25e-05	0.000336	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—IL6—acquired immunodeficiency syndrome	9.25e-05	0.00173	CbGpPWpGaD
Imiquimod—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.23e-05	0.000335	CcSEcCtD
Imiquimod—Headache—Ritonavir—acquired immunodeficiency syndrome	9.2e-05	0.000334	CcSEcCtD
Imiquimod—TLR7—Immune System—IL2—acquired immunodeficiency syndrome	9.16e-05	0.00172	CbGpPWpGaD
Imiquimod—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.99e-05	0.000326	CcSEcCtD
Imiquimod—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.92e-05	0.000324	CcSEcCtD
Imiquimod—Rash—Saquinavir—acquired immunodeficiency syndrome	8.91e-05	0.000324	CcSEcCtD
Imiquimod—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.9e-05	0.000323	CcSEcCtD
Imiquimod—Headache—Saquinavir—acquired immunodeficiency syndrome	8.85e-05	0.000322	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	8.73e-05	0.00163	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	8.73e-05	0.00163	CbGpPWpGaD
Imiquimod—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.72e-05	0.000317	CcSEcCtD
Imiquimod—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.57e-05	0.000311	CcSEcCtD
Imiquimod—Rash—Lamivudine—acquired immunodeficiency syndrome	8.5e-05	0.000309	CcSEcCtD
Imiquimod—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.49e-05	0.000308	CcSEcCtD
Imiquimod—Headache—Lamivudine—acquired immunodeficiency syndrome	8.45e-05	0.000307	CcSEcCtD
Imiquimod—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.4e-05	0.000305	CcSEcCtD
Imiquimod—Nausea—Lamivudine—acquired immunodeficiency syndrome	8.01e-05	0.000291	CcSEcCtD
Imiquimod—TLR8—Immune System—IL6—acquired immunodeficiency syndrome	7.11e-05	0.00133	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—acquired immunodeficiency syndrome	5.39e-05	0.00101	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	5.05e-05	0.000945	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	4.29e-05	0.000804	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	3.9e-05	0.000729	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	3.31e-05	0.00062	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.98e-05	0.00037	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	8.8e-06	0.000165	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	6.79e-06	0.000127	CbGpPWpGaD
